Brainsway Ltd. income statement

In fiscal 2025, Brainsway Ltd. reported revenue of $52.2m, up 27.3% on the year before, operating income of $4.3m (a 8.3% margin) and net income of $7.6m, or $0.18 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Brainsway Ltd.: income statement, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	11	16	23	22	30	27	32	41	52
Cost of revenue	3	4	5	5	7	7	8	10	13
Gross profit	9	13	18	17	23	20	23	31	39
Research and development	5	6	8	6	6	8	7	7	10
Operating income	−7	−5	−8	−5	−5	−13	−5	1	4
Interest expense	—	—	—	—	—	—	0	0	1
Income before tax	−7	−6	−10	−5	−6	−13	−4	3	8
Income tax	0	0	0	0	0	0	0	1	0
Net income	−7	−6	−10	−5	−6	−13	−4	3	8
Diluted EPS	—	—	—	—	−$0.21	−$0.40	−$0.13	$0.05	$0.18
Diluted shares (average)	15m	17m	21m	22m	31m	33m	33m	34m	38m
EBITDA	−7	−5	−8	−5	−5	−13	−5	2	5

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: BWAY vs IRIX BWAY vs SENS APYX vs BWAY

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Brainsway Ltd.'s SEC filings (10-K and 10-Q), retrieved November 2, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Brainsway Ltd.